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Abstract
The aim of this study was to investigate a possible link between cellular telephone use and risks for various diseases of the
central nervous system (CNS). We conducted a large nationwide cohort study of 420 095 persons whose first cellular
telephone subscription was between 1982 and 1995, who were followed through 2003 for hospital contacts for a diagnosis
of a CNS disorder. Standardized hospitalization ratios (SHRs) were derived by dividing the number of hospital contacts in the
cohort by the number expected in the Danish population. The SHRs were increased by 10–20% for migraine and vertigo. No
associations were seen for amyotrophic lateral sclerosis, multiple sclerosis or epilepsy in women. SHRs decreased by 30–40%
were observed for dementia (Alzheimer disease, vascular and other dementia), Parkinson disease and epilepsy among men.
In analyses restricted to subscribers of 10 years or more, the SHRs remained similarly increased for migraine and vertigo and
similarly decreased for Alzheimer disease and other dementia and epilepsy (in men); the other SHRs were close to unity. In
conclusion, the excesses of migraine and vertigo observed in this first study on cellular telephones and CNS disease deserve
further attention. An interplay of a healthy cohort effect and reversed causation bias due to prodromal symptoms impedes
detection of a possible association with dementia and Parkinson disease. Identification of the factors that result in a healthy
cohort might be of interest for elucidation of the etiology of these diseases.
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Introduction
The worldwide spread of the use of mobile phones has raised
concern about possible adverse health effects [1,2]. Most of the
epidemiological studies conducted so far have addressed the risk
for brain tumours. There is accruing evidence that mobile phone
use does not increase the risk for these tumours among short-term
users, but the picture is less clear for frequent users for 10 years or
more: whereas a substantial increase in risk is unlikely, a small-to-
moderate increase cannot be ruled out [3–7]. During operation of
a mobile phone, the antenna emits radiofrequency electromag-
netic fields (RF-EMF), which can penetrate 4–6 cm into the
human brain [8,9], leading to relatively localized exposure. Hence,
brain tumours are indeed a major outcome of interest, but for the
same reason it would be important to investigate the risks for other
diseases of the central nervous system (CNS). Recent reviews of
epidemiological studies of associations between exposure to
extremely low-frequency electromagnetic fields (ELF-EMF) in
certain occupations and the risk for CNS disease indicated
increased risks for Alzheimer disease and amyotrophic lateral
sclerosis (ALS) but not for vascular dementia, epilepsy or
Parkinson disease [10–12]. Despite the fact that the emission
from mobile phones is a combination of RF-EMF and pulsed ELF-
EMF [13], no studies have investigated the association between
use of mobile phones and risks for CNS disease.
In this registry-based study, we used a retrospective cohort of
Danish mobile phone subscribers between 1982 and 1995 to
compare their hospitalisation rates for CNS diseases with those of
the general population for the same diseases. To our knowledge,
this is the first study in which possible associations between mobile
phone use and the occurrence of migraine, vertigo and more
severe CNS diseases, such as Alzheimer disease, vascular
dementia, Parkinson disease, ALS, multiple sclerosis and epilepsy,
have been examined systematically.
Methods
The composition of the cohort has been described previously
[3]. In brief, we obtained the records of all 723 421 mobile phone
subscriptions in Denmark during the period 1982–1995. We
deleted 200 507 corporate subscriptions, as the individual users
could not be identified. A further 102 819 records were excluded
because of: duplicate addresses (one of them removed), errors in
name or address, a non-residential address, subscriber under 18
years of age at first subscription, subscriber a permanent resident
of Greenland or the Faroe Islands, or the subscriber asked to be
excluded from the study (n=53). The final study cohort comprised
420 095 private mobile phone subscribers.
We used the date of the first subscription as the entry date into
the cohort, but persons remained in the cohort even when they
stopped the respective subscription. We have done this for two
reasons. First, years since first mobile phone use were preferred to
the number of years of mobile phone use to estimate exposure in
most of the cancer-related mobile phone studies, too, and, if both
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an effect most likely attributable to the habit that the amount of
mobile phone use varies over time but persons who once started
using mobile phones rarely completely stop using them. Second,
starting with a new subscription requires a new identification of
the individual user and failure of identication of a former mobile
phone subscriber would be either an individual who has indeed
stopped using a mobile phone or an individual who remained to
be a subscriber but was not identified as such by us.
Through record linkage of cohort members by name and
address with the Central Population Register, their personal
identification numbers were obtained, with data on vital status and
date of death or emigration. Using the personal identification
number, we linked the cohort members to the files of the Hospital
Discharge Registry in order to ascertain hospitalisations for CNS
diseases. This Registry contains information on all hospitalisations
in Denmark since 1977, and, from 1994 onwards, information on
outpatients. Cohort members were followed until their first
hospital contact (hospitalisations up to 1994 and hospital contacts
thereafter) for each disease. Follow-up began on the date of first
subscription and ended on the date of first hospital contact, date of
death, date of emigration or 31 December 2003, whichever came
first. The following groups of CNS diseases were defined:
Alzheimer disease (ICD-10 F00.0,.1,.2,.9; G30.0,.1,.8,.9), vascular
dementia (ICD-10 F01.0,.1,.2,.3,.8,.9), other dementia (including
other specific disorders with dementia, unclassified dementia and
other unspecified degenerative CNS diseases; ICD-10 A81.0;
B22.0; F02.0,.1,.2,.3,.4,.8; F03.9; G10; G20 except G20.9;
G31.0,.1,.8,.9), Parkinson disease (ICD-10 G20.9), ALS (ICD-10
G12.2,.8,.9), multiple sclerosis (ICD-10 G35.9), and epilepsy (ICD-
10 G40; G41). Furthermore, we obtained information on
hospitalisations for migraine (ICD-10 G43) and vertigo (ICD-10
A88.1; H81.1; H81.3). All the diagnoses, including the action
diagnosis and up to 20 additional recorded diagnoses, were used as
indicators of the outcome. All the outcomes were measured after
hospital discharge requiring at least 24 h of admission or
outpatient visits to the hospital. This registry-based study was
approved by the Danish Ethical Committee System (KF 01-075/
96), the Danish Data Protection Board (1996-1200-121), and the
Danish Ministry of Justice (Jnr. 1996-760-0219) and did not
require written informed consent by participants. The cellular
telephone operators informed their subscribers about the study via
their newsletters and the possibility to demand exclusion was
provided to everyone, but only 53 subscribers (see above) refused
to be included.
The numbers of hospital contacts observed were compared with
those expected, which were calculated by multiplying the number
of person–years of cohort members by the overall and disease-
specific hospital contact rates for primary CNS disease among
men and women in the general population of Denmark, in 5-year
age groups and calendar periods of observation. In order to
exclude cohort members from the reference population, the
number of cases of each CNS disease and the respective person–
years observed in the cohort were subtracted from the corre-
sponding figures for the total Danish population, and a new set of
hospital contact rates was created. Standardized hospitalisation
ratios (SHRs) for the various CNS diseases (including migraine
and vertigo) and 95% confidence intervals (CIs) were calculated on
the assumption of a Poisson distribution of the observed diseases
[14]. The SHRs were calculated by gender and for both genders
combined, but because of the small number of cases of most CNS
diseases in the cohort or lack of difference in the gender-specific
effect estimates, only the SHRs for both genders combined are
presented in the tables; the only exception is epilepsy, because the
gender-specific effect estimates differed. The SHRs are also given
by latency, which was calculated as years between the time of first
subscription to a mobile phone and the first hospital contact for
the respective outcome.
As described earlier [3], we obtained additional data from
Statistics Denmark in order to compare the age- and gender-
specific average incomes of our cohort members with the
respective figures in the general population of Denmark.
Results
Overall, the 420 095 cohort members represented almost 4
million person–years at risk. As mobile phone use became popular
only in the mid-1990s, only 10?6% of all cohort members obtained
their first subscription before 1992 (Figure 1). Most subscriptions
(46?9%) were taken out in 1995. Before 1992, a large majority of
subscribers were in the intermediate age group (30–59 years;
80%), rather than younger (18–29 years, 16%) or older groups
($60 years, 4%). In 1995, the respective proportions were 62%,
31% and 7%. Women represented 62 542 (15%) of the cohort
members.
There was an overall small but statistically significant excess of
hospital contacts for migraine and vertigo among cohort members
(Table 1). The excess was smallest for subscribers of $10 years,
but the differences in effect estimates across the four latency
groups were generally small. Although the age-adjusted hospital
contact rates for migraine or vertigo were higher among women
(more than three times for migraine and about 2?5 times for
vertigo, a gender ratio similar to that observed in the general
population), the absolute numbers of affected women were much
smaller because there were fewer women in the subscriber cohort.
The effect estimates were, however, similar, being 1?2 for both
men and women for migraine and 1?1 for men and 1?2 for women
for vertigo.
The SHRs for Alzheimer disease, vascular dementia and other
dementia were all statistically significantly decreased (Table 2). A
significantly decreased SHR was also observed for Parkinson
disease, whereas the SHRs for ALS and multiple sclerosis were
close to unity. For epilepsy, there was a significantly decreased
SHR among men but not women, for which the SHR was slightly
above 1. Subscribers for $10 years or more were of particular
interest because of the longer latency, but the SHRs for this group
were all close to or below unity. Statistically significantly reduced
SHRs were seen for Alzheimer disease and for epilepsy among
males.
Figure 1. Year of first subscription to a cellular telephone for
the 420 095 members of the Danish retrospective cohort of
cellular telephone subscribers between 1982 and 1995.
doi:10.1371/journal.pone.0004389.g001
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Summary of Findings
In this cohort study of mobile phone subscribers between 1982
and 1995, we observed weak positive associations with migraine
and vertigo but inverse associations with Alzheimer disease,
vascular and other dementia, Parkinson disease and epilepsy
among men. No associations were seen with ALS, multiple
sclerosis or epilepsy among women. These findings were also made
for long-term subscribers, i.e. persons who had had a subscription
to a mobile phone for 10 or more years before their disease was
registered.
Headaches and dizziness are frequent self-reported symptoms
associated with mobile phone use [15–18], and the evidence that
these complaints are causally linked to exposure to RF-EMF is
weak [1,2]. This assessment is based mainly on the absence of
consistent effects in human provocation and sleep studies and on
the lack of a biologically plausible explanation, although
participants in a recent Swedish human provocation study
reported headache and vertigo more often after mobile phone
use than after sham exposure [19].
Our finding of a higher rate of hospital contacts for migraine
among mobile phone subscribers raises the question of what
factors lead to a hospital contact, as only a small proportion of
migraine patients are referred to hospital [20]. Although high
work load has been associated with migraine [21] and work-
related stress was more common in frequent mobile phone users in
a Swedish–Norwegian cross-sectional survey [18], we had no
reason to expect a higher initial rate of migraine in our cohort or a
greater likelihood of hospital contacts. The possibility that cohort
members with a higher average income than the general
population [3], working predominantly in occupations in which
mobile telecommunication is an advantage, prefer to go directly to
a specialized center in a hospital than to a general practitioner is
speculative. Our finding that the excess of migraine was more
frequent after the shortest latency might also indicate heightened
awareness among mobile phone users. There was, however, no
clear pattern of increasing risk for migraine or vertigo with time
between exposure and diagnosis of these outcomes.
We found reduced risks for a hospital contact for all types of
dementia, including Alzheimer disease, and for Parkinson disease.
As there is no biological evidence of a protective effect of mobile
phones [1], alternative explanations are needed. One alternative is
that the prodromal symptoms of these diseases reduce the
Table 1. Standardized hospitalisation ratios (SHRs) and 95%
confidence intervals (CIs) for migraine and vertigo among
420 095 subscribers to cellular telephones in Denmark, 1982–
1995, followed up through 31 December 2003.
Condition Latency (years)* Observed Expected SHR CI
Migraine 1 148 117.0 1.3 1.1–1.5
1–4 611 503.6 1.2 1.2–1.3
5–9 586 500.3 1.2 1.1–1.3
$10 56 53.3 1.1 0.8–1.4
Total 1401 1174.2 1.2 1.1–1.3
Vertigo 1 137 126.3 1.1 0.9–1.3
1–4 750 658.0 1.1 1.1–1.2
5–9 1148 1023.2 1.1 1.1–1.2
$10 191 187.1 1.0 0.9–1.2
Total 2226 1994.6 1.1 1.1–1.2
*Time since first subscription to a cellular telephone.
doi:10.1371/journal.pone.0004389.t001
Table 2. Standardized hospitalisation ratios (SHRs) and 95%
confidence intervals (CIs) for diseases of the central nervous
system among 420 095 subscribers to cellular telephones in




(years)* Observed Expected SHR CI
Alzheimer disease 1 1 5.4 0.2 0.0–1.0
1–4 25 33.1 0.8 0.5–1.1
5–9 50 63.4 0.8 0.6–1.0
$10 5 13.1 0.4 0.1–0.9
Total 81 114.9 0.7 0.6–0.9
Vascular dementia 1 2 4.3 0.5 0.1–1.7
1–4 19 26.8 0.7 0.4–1.1
5–9 34 52.9 0.6 0.4–0.9
$10 13 11.8 1.1 0.6–1.9
Total 68 95.7 0.7 0.5–0.9
Other dementia 1 21 40.1 0.5 0.3–0.8
1–4 131 198.7 0.7 0.5–0.8
5–9 198 257.5 0.8 0.7–0.9
$10 33 54.8 0.6 0.4–0.9
Total 383 551.1 0.7 0.6–0.8
Parkinson disease 1 10 21.4 0.5 0.2–0.9
1–4 82 106.0 0.8 0.6–1.0
5–9 110 136.1 0.8 0.7–1.0
$10 35 31.6 1.1 0.8–1.5
Total 237 295.1 0.8 0.7–0.9
Amyotrophic lateral
sclerosis
1 11 8.1 1.4 0.7–2.4
1–4 42 37.2 1.1 0.8–1.5
5–9 44 44.5 1.0 0.7–1.3
$10 7 10.1 0.7 0.3–1.4
Total 104 99.9 1.0 0.9–1.3
Multiple sclerosis 1 61 51.3 1.2 0.9–1.5
1–4 222 217.4 1.0 0.9–1.2
5–9 220 211.1 1.0 0.9–1.2
$10 25 29.4 0.9 0.6–1.3
Total 528 509.3 1.0 0.9–1.1
Epilepsy (men) 1 201 249.9 0.8 0.7–0.9
1–4 752 1015.4 0.7 0.7–0.8
5–9 716 979.4 0.7 0.7–0.8
$10 98 176.0 0.6 0.5–0.7
Total 1767 2420.6 0.7 0.7–0.7
Epilepsy (women) 1 41 37.1 1.1 0.8–1.5
1–4 156 145.2 1.1 0.9–1.3
5–9 135 129.0 1.0 0.9–1.2
$10 5 7.1 0.7 0.2–1.6
Total 337 318.4 1.1 0.9–1.2
*Time since first subscription to a cellular telephone.
doi:10.1371/journal.pone.0004389.t002
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the findings for vascular dementia and particularly for Parkinson
disease, for which the inverse association was stronger with shorter
latency. For Alzheimer disease and other dementia, the picture is
less clear, as an inverse association was also seen for persons who
had a subscription $10 years before hospitalisation. Moreover, the
age distribution of our cohort suggests that the start of subscription
for most cohort members would have been before the typical age
of onset of dementia. Differences in hospitalisation patterns
between cohort members and the general population is another
possibility; however, as Denmark ensures tax paid, free, equal
access to medical health care, this is unlikely.
Our cohort differed in many social and lifestyle aspects from the
general population [3], with a higher average income, which is
related to a healthier lifestyle. The members were theoretically at
lower risk for dementia, as the risk for dementia appears to
decrease with a healthy diet [22–24], among nonsmokers [25], and
with participation in mental, physical and social activities [22–26],
all of which might be assumed to be more common in our cohort
than in the general population. This alone, however, might not
explain the 30% decrease in risk, as income is only a proxy for a
healthy lifestyle. Furthermore, while the income difference
between our cohort and the general population was restricted to
men, the decrease in risk was also observed among women.
Therefore, it will be important to investigate further the
characteristics of our cohort members, such as occupation and
lifestyle, in order to identify new hypotheses for the potential risk
factors for dementia.
Epilepsy in our study comprised a mixture of idiopathic and
symptomatic epilepsies and both prevalent and incident epilepsy,
as many cases are diagnosed at an early age, before persons
subscribe to a mobile phone [27]. The rate of hospital contacts for
epilepsy was decreased among men, perhaps again reflecting a
healthy cohort effect or less frequent participation in control
examinations by ‘busy’ mobile phone users. There is no
straightforward explanation for the restriction of the inverse
association to men, but, as discussed below, a healthy cohort effect
can be expected to be stronger among men. Furthermore, in
Denmark, epileptic subtypes, and therefore susceptibility to their
development, differ between genders [28].
We found no association between mobile phones use and ALS
and multiple sclerosis. ALS was of particular interest because
previous epidemiological studies suggested an association with
occupational exposure to power-frequency EMF [10]. The
negative finding of our study does not weaken the earlier
observations, as the nature of the exposure is quite different;
however, it provides a first indication that RF-EMF are not a
strong risk factor for ALS.
Strengths and limitations
Our approach has several strengths. First, the nationwide
coverage of subscribers to all Danish mobile phone operators at
that time enabled us to achieve the best possible representativity.
Secondly, the large size of the cohort and the long follow-up
period resulted in effect estimates with narrow confidence
intervals. By eliminating exposed cohort members, i.e. mobile
phone subscribers, from the comparison population in the
calculations of SHRs, we removed a potential source of
underestimation of an association. Additionally, we were able to
address possible associations many years after first mobile phone
subscription. Further strengths of our study are the use of the
national Hospital Discharge Registry, which enabled us to
investigate morbidity instead of mortality. This Registry is an
administrative database which collects data independently of our
study hypotheses, providing unbiased data on our outcomes of
interest. Outpatients, however, were recorded only from 1994
onwards. We were able to obtain additional data on income from
Statistics Denmark and self-reported mobile phone use in a smaller
sub-cohort, which assisted us in interpreting our findings.
Furthermore the use of an objective measure of exposure, years
of subscription, derived from the files of all Danish network
providers, increased the possibility of avoiding several methodo-
logical limitations inherent in self-reported information on mobile
phone use [29].
The study also has limitations. First, use of subscription
information raises the possibility of exposure misclassification. Users
of mobile phones whose subscriptions are not listed under their
names were classified as unexposed in this study and were included
in the general population rates used to compute expected values.
Furthermore, subscribers who did not actually use a mobile phone
wereclassifiedasexposed. Themisclassificationderiving from use of
subscriber data is, however, non-differential, so that the expected
directionofanybias would be towardunderestimationofa true risk.
In a previous validation study of our cohort [30], we evaluated the
potential for bias by comparing our subscriber list with self-reported
information from 822 Danes participating as controls in a case–
control study of the possible association between brain tumour risk
and use of mobile phones [31]. More than 60% of controls
identified in the subscriber cohort characterized themselves as
making or receiving calls at least once a week, while the comparison
population of non-subscribers included only 16% of such users;
hence, the subscriber cohort contains about four times as many
regular mobile phone users as the comparison population of non-
subscribers. We do not know, however, whether this held true for
patients with the outcomes studied in the present analyses.
A second potential limitation of our study is the exclusion of
users whose subscription was in the name of their company. This
might not only have reduced the proportion of users but perhaps
excluded some of the most active ones. We also had no
information on new subscribers after 1995, who were therefore
included in the reference population. Thus, most of our reference
population consists of recent mobile phone users, which could
result in underestimation of any association. It is therefore
particularly important to subdivide the cohort by latency, as
subscribers for $10 years were found only in the cohort members.
A third potential limitation is our finding that the persons who
subscribed to mobile phones between 1982 and 1995 had a higher
income than the general population, opening the possibility of a
healthy cohort effect [3]. This is a particular concern for diseases
related to a healthy lifestyle, such as less smoking and a healthy
diet, and also suggests more frequent contact with hospitals for
neurological symptoms. We found that our cohort had reduced
incidence rates of lung cancer and many other lifestyle-associated
cancers among men [3]. These limitations must be kept in mind in
interpreting our findings.
Measuring migraine and vertigo by hospital contacts also has
limitations. Vertigo in particular is a broad diagnostic group, used
also for dizziness or similar symptoms of an unknown CNS
disorder, and can be due to vestibular or cardiac anomalies. While
for some patients vertigo is an early symptom of a CNS disorder
identified later, for others it is only a short symptomatic episode.
Nevertheless, a true association between mobile phone use and
vertigo remains a concern, as having an attack in situations such as
driving a car or bicylce could have serious consequences.
Conclusions
It is important to start studying other diseases than brain
tumours in relation to mobile phone use, as there are no strong
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is the first to investigate a possible association between use of
mobile phones and risk of CNS disorders. Most of the observed
associations are probably not related to the RF-EMF exposure
from mobile phones. Since the study includes the entire population
of Denmark and there is no lost to follow-up, the results reflect
causality, confounding or an unequal distribution of determinants
for being hospitalised like comorbidity. Healthcare behaviour may
also be related to mobile phone use affecting especially the results
for diseases that only occasionally lead to hospitalisation.
With regard to dementia, an interplay of a healthy cohort effect
and reversed causation bias due to prodromal symptoms impedes
detection of a possible association, although identification of the
factors that contribute to the healthy cohort would be of interest
for determining the aetiology of dementia. As interviewed-based
case–control studies such as those used to investigate mobile phone
use and cancer risk [1] are not an option for dementia, the only
study type for addressing this research question would be a
prospective cohort study. We observed no association between
mobile phone use and ALS, which is reassuring, as this disease has
been reported to be associated with occupational exposure to ELF-
EMF [10,11].
The weak but statistically significant associations between
mobile phone use and migraine and vertigo deserve further
attention. Owing to the high prevalences of these conditions, our
observed 10–20% excess of hospitalisations, which reflect only a
small proportion of the occurrence of these syndromes, is related
to the large absolute numbers of affected persons in our cohort.
This would represent a serious public health problem if the
associations are confirmed. As a higher risk for car accidents is the
only scientifically established adverse consequence of mobile
phone use [32], the roles of vertigo, dizziness and headache
associated with mobile phone use should be further examined.
This study endorses public health recommendations for prudent
use of mobile phones, including using wired hand-free sets or other
exposure-reducing measures, until more evidence about the
possible health effects has been obtained.
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